Despite being approved for use by the FDA in 2019, many questions remain on the safety, tolerability, and efficacy of ubrogepant in certain patient populations with migraine in the real-world population....
Luke Joseph Laffin, MD, from the Cleveland Clinic Foundation, answers our questions about his research on the effect of phase 2 cardiac rehabilitation on exercise capacity and outcomes in patients with...
New research indicates that many women living with HIV may prefer a monthly long-acting injectable antiretroviral therapy, once FDA-approved, instead of daily pills. Consultant360 discussed these findings...
Consultant360 spoke with Karen Hansen, MD, whose study suggests that parathyroid hormone may be an independent predictor of fractures, vascular events, and mortality in some patients with chronic kidney...
Edward L. Barnes MD MPH, from the University of North Carolina at Chapel Hill, answers questions about the management of pouchitis in ulcerative colitis, a topic he discussed during his session at the...
Dr Scott E Hadland from Boston Medical Center discusses his latest research, which demonstrated that prescribing medication earlier to youth with opioid use disorder improves retention in care vs behavioral...
Richard J. Santen, MD, answers questions about his article on the importance of determining the underlying risk of breast cancer for individual patients before initiating menopausal hormone therapy.
A new review indicates that newer, advanced MRI technology can serve as a “promising alternative” to subjective landmark-based methods for transcranial high intensity focused ultrasound targeting....
Adults use health care services more frequently when they are exposed to wildfire smoke, but the use among children is not as clear. Sydney Leibel, MD, MPH, from Rady Children and Hospital, answers our...
